Evidence map›Paper›PMID 37577801›Full record

Trial reportStroke2023

Electric Field Navigated 1-Hz rTMS for Poststroke Motor Recovery: The E-FIT Randomized Controlled Trial.

Dylan J Edwards, Charles Y Liu, Kari Dunning, Felipe Fregni, Jarmo Laine, Benjamin E Leiby, Lynn M Rogers, Richard L Harvey

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03010462 (A Prospective, Multi-center, Randomized, Sham-controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 hz Rtms Administered to the Contralesional Hemisphere as Adjuvant to Task-oriented Rehabilitation in Patients With Ischemic Stroke), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03010462 nacompletednot on this map

A Prospective, Multi-center, Randomized, Sham-controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 hz Rtms Administered to the Contralesional Hemisphere as Adjuvant to Task-oriented Rehabilitation in Patients With Ischemic Stroke

TypeinterventionalSponsorNexstim LtdRan2017 to 2018Enrolled60ConditionsIschemic StrokeArmsNexstim NBS guided active rTMS, Nexstim NBS guided sham rTMS
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Advances in Stroke Neurorehabilitation.Journal of clinical medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 3 countries.

Dylan J EdwardsMoss Rehabilitation Research Institute, and Department of Rehabilitation Medicine Thomas Jefferson University, Philadelphia, PA (D.J.E.).ORCID 0000-0001-7346-3100
Charles Y LiuUSC Neurorestoration Center, Rancho Los Amigos National Rehabilitation Center, Los Angeles, CA (C.Y.L.).ORCID 0000-0001-6423-8577
Kari DunningDepartment of Rehabilitation, Exercise and Nutrition Sciences, University of Cincinnati, OH (K.D.).
Felipe FregniSpaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA (F.F.).
Jarmo LaineNexstim Corporation, Helsinki, Finland (J.L.).
Benjamin E LeibyDivision of Biostatistics, Thomas Jefferson University, PA (B.E.L.).ORCID 0000-0003-0761-8383
Lynn M RogersThe Shirley Ryan AbilityLab, Northwestern University Feinberg School of Medicine, Chicago, IL (L.M.R., R.L.H.).
Richard L HarveyThe Shirley Ryan AbilityLab, Northwestern University Feinberg School of Medicine, Chicago, IL (L.M.R., R.L.H.).ORCID 0000-0001-6763-169X
Edith Cowan University · AUHarvard University · USNexstim (Finland) · FINorthwestern University · USRancho Los Amigos National Rehabilitation Center · USShirley Ryan AbilityLab · USThomas Jefferson University · USUniversity of Cincinnati · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo determine if low-frequency repetitive transcranial magnetic stimulation targeting the primary motor cortex contralateral (M1

methodsThe present E-FIT trial (Electric Field Navigated 1Hz rTMS for Post-stroke Motor Recovery Trial) included 5 of 12 NICHE trial outpatient US rehabilitation centers. The stimulation protocol remained identical (1 Hz repetitive transcranial magnetic stimulation, M1

resultsOf 60 participants randomized, 58 completed treatment and were included for analysis. Bayesian analysis of combined data from the E-FIT and the NICHE trials indicated that active treatment was not superior to sham at the primary end point (posterior mean odds ratio of 1.94 [96% credible interval of 0.61-4.80]). For the E-FIT intent-to-treat population, upper extremity Fugl-Meyer improvement ≥5 pts occurred in 60% (18/30) active group and 50% (14/28) sham group. Participants enrolled 3 to 6 months following stroke had a 67% (31%-91% CI) response rate in the active group at the 6-month end point versus 50% in the sham group (21.5%-78.5% CI). There were significant improvements from baseline to 6 months for both active and sham groups in upper extremity Fugl-Meyer, Action Research Arm Test, and EQ-5D (

conclusionsIntensive motor rehabilitation 3 to 12 months after stroke improved clinical impairment, function, and quality of life; however, 1 Hz-repetitive transcranial magnetic stimulation was not an effective treatment adjuvant in the present sample population with mixed lesion location and extent. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03010462.

Indexed as

StrokeStroke RehabilitationBayes TheoremHumansQuality of LifeRecovery of FunctionTranscranial Magnetic StimulationTreatment OutcomeUpper Extremityodds ratiooutpatientsquality of lifestroketherapeuticsupper extremity

Identifiers

PMID37577801
PMCPMC10453351
OpenAlexW4385797919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.